Table 3.
Patients’ characteristics by cancer site.
| Characteristics | Breast N = 18,644 |
Lung N = 21,552 |
Colorectal N = 9,955 |
|---|---|---|---|
| Age at diagnosis (year) | 63.2 (13.4) | 68.8 (10.9) | 70.2 (12.6) |
| Sex | |||
| Women | 100% | 41.6% | 48.0% |
| Men | – | 58.4% | 52.0% |
| Race | |||
| Non-Hispanic Whites | 87.8% | 91.3% | 86.8% |
| Non-Hispanic Blacks | 10.1% | 7.5% | 11.2% |
| Hispanics | 2.1% | 1.3% | 2.1% |
| Year of diagnosis | |||
| 1996–2000 | 29.5% | 29.1% | 33.3% |
| 2001–2005 | 26.4% | 26.3% | 27.1% |
| 2006–2010 | 44.1% | 44.6% | 39.7% |
| Stage of diagnosis | |||
| Localized | 67.8% | 16.2% | 33.1% |
| Regional | 23.2% | 23.1% | 38.4% |
| Distant | 4.1% | 41.5% | 17.5% |
| Unknown | 5.0% | 19.3% | 11.1% |
| Treatment | |||
| Surgery | |||
| Yes | 93.2% | 24.0% | 86.5% |
| No | 6.8% | 76.0% | 13.5% |
| Radiation | |||
| Yes | 28.5% | 33.4% | 2.5% |
| No | 71.5% | 66.6% | 97.5% |
| Chemotherapy | |||
| Yes | 21.3% | 29.1% | 20.0% |
| No | 78.7% | 70.9% | 80.0% |
| Hormone therapy | |||
| Yes | 14.4% | 0.4% | 0.2% |
| No | 85.6% | 99.6% | 99.8% |
| Smoking status | |||
| Never | 45.5% | 8.0% | 39.8% |
| Former | 18.8% | 34.6% | 25.9% |
| Current | 11.9% | 32.5% | 10.7% |
| Unknown | 23.7% | 24.8% | 23.6% |
| Marital status | |||
| Married | 58.1% | 54.4% | 57.4% |
| Single | 39.0% | 42.1% | 39.4% |
| Unknown | 3.0% | 3.5% | 3.2% |
| Health insurance | |||
| Uninsured | 2.6% | 2.8% | 2.4% |
| Private | 24.5% | 9.8% | 12.2% |
| Medicaid | 3.8% | 5.1% | 3.2% |
| Medicare | 14.7% | 19.9% | 20.4% |
| Medicare with supplement | 29.6% | 35.4% | 39.6% |
| Other | 16.0% | 10.3% | 9.5% |
| Unknown | 8.8% | 16.8% | 12.9% |
| Five-year survival rate | 82.6% | 17.0% | 58.3% |